Statin Current Events | Statin News | 2
|
| Page
2 of
6 |
117 Results |
|
|
|
Sort By:
Page Views | Date |
No reason to fear very low LDL
Very low LDL cholesterol levels appear to be safe for heart patients on statin therapies, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology. view more (2005-10-12)
Researchers find specific statin significantly reduces Alzheimer's and Parkinson's disease risk
Researchers from Boston University School of Medicine (BUSM) have found that the statin, simvastatin, reduces the incidence of Alzheimer's disease and Parkinson's disease by almost 50 percent. view more (2007-07-19)
Intensive statin therapy may partially reverse plaque build-up in arteries
A study presented today at the American College of Cardiology's 55th Annual Scientific Session demonstrates, for the first time, that very intensive cholesterol lowering with a statin drug can regress (partially reverse) the buildup of plaque in the coronary arteries. view more (2006-03-14)
Statins show dramatic drug and cell dependent effects in the brain
Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. view more (2009-10-29)
Statins Should Be Routine Therapy For People With Diabetes (p 2000, 2005)
The risk of cardiovascular disease for people with diabetes could be substantially reduced with the routine use of statins, conclude authors of a study in this week's issue of THE LANCET. Statins (a class of cholesterol-lowering drugs) have proven efficacy in reducing cardiovascular risk, even among people with normal cholesterol concentrations;... view more... (2003-06-11)
MSU researcher studies ties between cholesterol drugs, muscle problems
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users. view more (2008-11-12)
Early statin therapy for patients with acute coronary syndromes reduces death, cardiovascular events
Early, intensive therapy with statin medications reduces death and cardiovascular events for patients who have had heart attacks or other acute heart events. view more (2006-09-26)
MU Researchers Find Statin Drugs Also May Help Reduce Risk of Heart Failure, Sudden Cardiac Death
Statin drugs, known primarily for their ability to lower cholesterol, also may reduce the overactive sympathetic nervous system response that contributes to the worsening of heart failure and increases the risk of sudden cardiac death. view more (2007-05-02)
Cholesterol-lowering drugs not associated with reduced colorectal cancer risk
Use of cholesterol reducing drugs is not associated with a reduced risk of colorectal cancer, according to a study in the January 4 issue of the Journal of the National Cancer Institute . view more (2006-01-04)
Statins linked to lower risk of infection
Researchers at Johns Hopkins may have discovered an unintended benefit in the drugs millions of Americans take to lower their cholesterol: The medications, all statins, seem to lower the risk of a potentially lethal blood infection known as sepsis in patients on kidney dialysis. view more (2007-04-06)
EZETROL® Co-Administration with Statin Therapy Results in Greater LDL Cholesterol Lowering and Goal Attainment for Patients with Diabetes and Metabolic Syndrome, Studies Reveal
Results from two new clinical trials show that patients with diabetes and metabolic syndrome who are treated with ezetimibe (EZETROL®) co-administered with a statin experience greater reductions in LDL ("bad") cholesterol, compared to patients taking a statin alone. The new data also demonstrates that patients with diabetes and... view more... (2004-09-07)
ESC Congress 2003: Amount of blood LDL reduction relates to change of coronary plaque composition.
IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology We successfully demonstrated the clinical effect of statin on structural changes of coronary... view more... (2003-08-31)
New research shows neuroprotective effect of lovastatin
High cholesterol levels are considered to be a risk factor for cardiovascular disease including stroke. view more (2008-04-10)
Most Cardiologists Believe That LDL Cholesterol Should Be Lowered
Beyond Current Guidelines for Patients with Risk Factors, Reveals New Pan-European Survey view more (2004-08-31)
The Statin Wars: Why AstraZeneca Must Retreat (p 1341)
On Thursday 23 October, AstraZeneca, one of the world's largest pharmaceutical companies, will announce its third-quarter financial results. This coincides with a robust editorial in this week's issue of THE LANCET which calls into question AstraZeneca's high-profile marketing of rosuvastatin, a drug launched into the global statin market last... view more... (2003-10-22)
Statin therapy may lower mortality in heart failure patients
Cholesterol-lowering statin therapy may improve survival in patients with diastolic heart failure (DHF) according to a paper published in Circulation: Journal of the American Heart Association by cardiologists at Wake Forest University Baptist Medical Center. view more (2005-07-25)
Statins reduce loss of function, keeping old lungs young - even in smokers
Statins are known to be good for lowering cholesterol and maybe even fighting dementia, and now they have another reported benefit: they appear to slow decline in lung function in the elderly- even in those who smoke. view more (2007-10-12)
Fish oil and red yeast rice studied for lowering blood cholesterol
A great deal of scientific evidence shows that cholesterol-reducing medications known as statins can help prevent coronary artery disease. view more (2008-07-09)
New Data Reinforces Greater Efficacy of Ezetimibe Together with Statin Therapy
Studies Demonstrate Greater Cholesterol Lowering Effect of Dual Inhibition of Two Sources of Cholesterol SEVILLE, SPAIN, 19 APRIL, 2004 -- Merck & Co., Inc. and Schering-Plough Corporation today announced results from studies presented at the European Atherosclerosis Society (EAS) conference in Seville. The results from these studies... view more... (2004-04-21)
First comprehensive paper on statins' adverse effects released
A paper co-authored by Beatrice Golomb, MD, PhD, associate professor of medicine at the University of California, San Diego School of Medicine and director of UC San Diego's Statin Study group cites nearly 900 studies on the adverse effects of HMG-CoA reductase inhibitors (statins), a class of drugs widely used to treat high cholesterol. view more (2009-01-27)
|
|
| Page
2 of
6 |
117 Results |
|
|
|
Sort By:
Page Views | Date |
|
